Lipid modification – a summary of the drugs advised by NICE

11th October 2021 by Dr Louise Hudman

Lipid modification – a summary of the drugs advised by NICE

NICE has recently released guidance on the use of bempedoic acid in lipid modification. This prompted me to look back at the guidance on lipid modification and I came across a useful document from NICE called a ‘Key Therapeutic Topic’.

They are not guidance per se, but outline different medication options and link into other NICE guidance, so they are quite useful. There are plenty of others too.

Given my knowledge of when to add in ezetimibe and the other medications was a bit hazy and given the new guidance on bempedoic acid, I thought it useful to do a bit of a summary on what we should use and when.

What different guidelines are available from NICE on lipid modification?

Read for free

Sign up to access everything.

Free trial

Login

Already a member? Login to view this content.

Login

More cardiology guidelines

"Work as GP locum provides me both flexibility and autonomy together with great job satisfaction. However, there are some complexities one needs to address in starting out and doing everything right.

I've generally found answers to any issues I've had on the NASGP website – an excellent repository of very relevant information. The blog and magazines alone are almost worth the small costs of membership. The fact that NASGP is run by motivated fellow GPs gives me confidence in their guidance and advice.

LocumDeck makes my running things as a self-employed GP almost effortless - I don't think I would want to work without it. Invoicing is streamlined and the website is very user-friendly. After a busy week at work, the last thing you want is to spend hours on business admin. LocumDeck is a real timesaver.
"

Dr James O’Mahony

See the full list of features within our NASGP membership plans

Membership